67-6

50/93

) Tamura Y. Ectopic fat, insulin resistance and metabolic disease in non-obese Asians: inves-tigating metabolic gradation. Endocr J, 2019; 66: 1-9.) Watada H. Unappreciated role of low-density lipoprotein receptor-related protein 1 in pancre-atic β cells: Multiple roles of low-density lipo-protein receptor-related protein 1 in glucose and lipid metabolism. J Diabetes Investig. 2019; 10: 216-218.) Honda D, Ohsawa I,Takahashi K, Takahara H, Shoji K, Nagano M, Rinno H, Tomino Y, Suzuki Y: Significant fluctuations in total complement hemolytic activity as a nutri-tional parameter after transition from hemo-dialysis to online hemodiafiltration. Juntendo Medical Journal. 2019; 65: 77-84.) Myette JR, Kano T, Suzuki H, Sloan SE, 558 22) Katahira T, Kanazawa A, Shinohara M, Koshibu M, Kaga H, Mita T, Tosaka Y, Komiya K, Miyatsuka T, Ikeda F, Azuma K, Takayanagi N, Ogihara T, Ohmura C, Miyachi A, Mieno E, Yamashita S, Watada H: Post-prandial Plasma Glucagon Kinetics in Type 2 Diabetes Mellitus: Comparison of Immuno-assay and Mass Spectrometry. J Endocr Soc. 2019; 3: 42-51. 23) Mita T, Katakami N, Okada Y, Yoshii H, Osonoi T, Nishida K, Shiraiwa T, Torimoto K, Kurozumi A, Wakasugi S, Gosho M, Shimomura I, Watada H. Protocol of a Prospective Obser-vational Study on the Relationship Between Glucose Fluctuation and Cardiovascular Events in Patients with Type 2 Diabetes. Diabetes Ther. 2019; 10: 1565-1575. 24) Ohmura H, Mita T, Matsuoka J, Nojiri S, Nishizaki Y, Watada H, Daida H: Real-World Data on the Incidence of Macrovascular Complications in Japanese Patients with Type 2 Diabetes: The Sitagliptin Registration Type 2 Diabetes-Juntendo Collaborating Project. Diabetes Ther. 2019; 10: 1099-1111. 25) Someya Y, Tamura Y, Kaga H, Nojiri S, Shimada K, Daida H, Ishijima M, Kaneko K, Aoki S, Miida T, Hirayama S, Konishi S, Hattori N, Motoi Y, Naito H, Kawamori R, Watada H: Skeletal muscle function and need for long-term care of urban elderly people in Japan (the Bunkyo Health Study): a prospec-tive cohort study. BMJ Open, 2019; 9: e031584. 26) Tomiyama H, Ohkuma T, Ninomiya T, Mastumoto C, Kario K, Hoshide S, Kita Y, Inoguchi T, Maeda Y, Kohara K, Tabara Y, Nakamura M, Ohkubo T, Watada H, Munakata M, Ohishi M, Ito N, Nakamura M, Shoji T, Vlachopoulos C, Aboyans V, Yamashina A, Collaborative Group for J BAVELs. Steno- Stiffness Approach for Cardiovascular Disease Risk Assessment in Primary Prevention. Hypertension. 2019; 73: 508-513. 27) Watada H, Kaneko S, Komatsu M, Agner BR, Nishida T, Ranthe M, Nakamura J: Superior HbA1c control with the fixed-ratio combina-tion of insulin degludec and liraglutide (IDeg-Lira) compared with a maximum dose of 50 units of insulin degludec in Japanese individ-uals with type 2 diabetes in a phase 3, double-blind, randomized trial. Diabetes Obes Metab. 2019; 21: 2694-2703.＊ 28) Suzuki R, Tamura Y, Takeno K, Kakehi S, Funayama T, Furukawa Y, Kaga H, Sugimoto D, Kadowaki S, Someya Y, Kanazawa A, Kawamori R, Watada H: Three days of a eucaloric, low-carbohydrate/high-fat diet increases insulin clearance in healthy non- obese Japanese men. Sci Rep. 2019; 9: 3857. 29) Gomes M B, Rathmann W, Charbonnel B, Khunti K, Kosiborod M, Nicolucci A, Pocock S J, Shestakova M V, Shimomura I, Tang F, Watada H, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Surmont F, Ji L: Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study. Diabetes Res Clin Pract. 2019; 151: 20-32. 30) Nicolucci A, Charbonnel B, Gomes M B, Khunti K, Kosiborod M, Shestakova M V, Shimomura I, Watada H, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Surmont F, Tang F, Pocock S: Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme. Diabetes Obes Metab. 2019; 21: 2474-2485.〈Reviews〉 1 2Nephrology〈Original Articles〉 1 2